Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD

NCT02551172 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemias

Interventions

DRUG: HCP1105
DRUG: HGP0816
DRUG: Placebo of HCP1105
DRUG: Placebo of HGP0816

Sponsor

Hanmi Pharmaceutical Company Limited